Vector Laboratories Revenue and Competitors

Location

$10M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vector Laboratories's estimated annual revenue is currently $17.4M per year.(i)
  • Vector Laboratories received $Undisclosed in venture funding in April 2016.
  • Vector Laboratories's estimated revenue per employee is $155,000
  • Vector Laboratories's total funding is $10M.

Employee Data

  • Vector Laboratories has 112 Employees.(i)
  • Vector Laboratories grew their employee count by 14% last year.

Vector Laboratories's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP, ProductReveal Email/Phone
3
VP, OperationsReveal Email/Phone
4
VP, CommercialReveal Email/Phone
5
Director Quality Control and R&DReveal Email/Phone
6
Sr Director, Commercial OperationsReveal Email/Phone
7
Senior Director, Brand & MarketingReveal Email/Phone
8
Director, Market DevelopmentReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Director Program ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Vector Laboratories?

Vector Laboratories is a worldwide leader in the development and commercialization of labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA detection & glycobiology. We have developed a number of key technologies that revolutionized the field of IHC including VECTASTAIN® ABC systems, ImmPRESS Micropolymer Reagents, Mouse on Mouse (M.O.M.) Immunodetection Systems, and VECTASHIELD® Antifade Mounting Media for fluorescence applications. We are fully committed to developing new research tools to help scientists reach new visualization frontiers. Over the past 40 years, our products have enabled progress in biomedical research and medicine and have been cited in over 300,000 publications worldwide. Vector Laboratories is an independent, privately-held California corporation with a subsidiary in the U.K. Our products are also available worldwide through a network of independent distributors. Vector Laboratories is now part of Maravai LifeSciences following the strategic equity investment made in 2016.

keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Diagnostics,Pharmaceuticals

$10M

Total Funding

112

Number of Employees

$17.4M

Revenue (est)

14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vector Laboratories News

2022-04-17 - Nucleic Acid Labeling Market Size And Forecast | Agilent ...

... Merck KGaA (Germany), New England Biolabs, Perkinelmer Promega Corporation, Thermo Fisher Scientific Vector Laboratories.

2022-04-17 - Immunofluorescence Market Research Report, Business ...

... Biocare Medical, LLC; Abcam plc; Bio-Rad Laboratories ... Inc.; Sino Biological Inc.; Beckman Coulter, Inc.; Vector Laboratories;...

2022-03-30 - Vector Laboratories Adds Kum Ming Woo to Executive Team ...

Vector Laboratories empowers scientific advances with innovative proteomic and glycomic solutions. Supporting industries worldwide for 45 years...

2021-09-07 - Vector Laboratories Completes $124 Million Buyout; Initiates Acquisition Strategy; Appoints Former 10x Genomics and Maravai LifeSciences Exec as CEO; Launches VectaMount Express

BURLINGAME, Calif., Sept. 7, 2021 /PRNewswire/ -- Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has closed a $124 million cash buyout, backed by private equity firm Thompson Street C ...

2016-04-07 - Vector Laboratories Receives Strategic Investment from GTCR

Vector Laboratories, Inc., a Burlingame, California-based life science tools company, received a strategic investment of undisclosed amount. Private equity firm GTCR made the investment via Maravai LifeSciences management partnership with CEO Carl Hull, a 30-year veteran of the diagnostics and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.4M11626%N/A
#2
$11.7M11722%$150M
#3
$25.7M117-12%N/A
#4
$18.3M118-12%$137.8M
#5
$19.6M119-5%N/A

Vector Laboratories Funding

DateAmountRoundLead InvestorsReference
2016-04-08$UndisclosedUndisclosedGTCRArticle